TAI'AN, China, July 29 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the
"Company"), one of the leading plasma-based biopharmaceutical
companies in the People's Republic of
China ("PRC"), operating through its indirect majority-owned
subsidiaries, Shandong Taibang Biological Products Co. Ltd.
("Taibang") and Guiyang Dalin Biologic Technologies Co., Ltd.
("Dalin") and its equity investment in Xi'an Huitian Blood Products
Co., Ltd. ("Huitian"), today announced that Mr. Y. Tristan Kuo, the Company's Chief Financial
Officer, will present at the Canaccord Genuity 30th Annual Growth
Conference (the "Conference"), on August 11,
2010 at 1:00 p.m. ET. The
Conference will be held from August 10-12,
2010 at the InterContinental Boston Hotel, in Boston, Massachusetts. Mr. Kuo will also be
available for one on one meetings with investors and analysts at
the conference.
For more information about the conference and registration,
please contact Nadine Miller at
nmiller@canaccordgenuity.com .
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its
equity investment in Xi'an Huitian Blood Products Co., Ltd., is
currently the largest non-state-owned plasma-based
biopharmaceutical company in China. The Company is a fully integrated
biologic products company with plasma collection, production and
manufacturing, research and development, and commercial operations.
The Company's plasma-based biopharmaceutical products are
irreplaceable during medical emergencies, and are used for the
prevention and treatment of various diseases. The Company sells its
products to hospitals and other healthcare facilities in
China. Please see the Company's
website http://www.chinabiologic.com for additional
information.
For more information, please contact:
Company Contact:
Mr. Y. Tristan Kuo
Chief Financial Officer
China Biologic Products, Inc.
Tel: +86-538-6202206
Email: IR@chinabiologic.com
Web: http://www.chinabiologic.com
Investor Relations Contact:
Mr. Kalle Ahl, Account Manager
CCG Investor Relations
Tel: +1-646-833-3417
Email: kalle.ahl@ccgir.com
Web: http://www.ccgirasia.com
Mr. Crocker Coulson, President
Tel: +1-646-213-1915
Email: crocker.coulson@ccgir.com
SOURCE China Biologic Products, Inc.